Comparison

Sweroside European Partner

Item no. TMO-T6S2252-5mg
Manufacturer TargetMol
CASRN 14215-86-2
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 20 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 99.71%
Citations Ozturk N , Korkmaz S , Ozturk Y , et al. EFFECTS OF GENTIOPICROSIDE, SWEROSIDE AND SWERTIAMARINE, SECOIRIDOIDS FROM GENTIAN (GENTIANA LUTEA SSP. SYMPHYANDRA), ON CULTURED CHICKEN EMBRYONIC FIBROBLASTS[J]. Planta Medica, 2006, 72(04):289-294.
Smiles OC[C@H]1O[C@@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 14215-86-2
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
358.34
Description
1. Sweroside possesses strong hepatoprotective effect. 2. Sweroside is a promising osteoporosis therapeutic natural product, has anti-osteoporotic effect on the human MG-63 cells and rat osteoblasts.
Pathways
Others
Bioactivity
1. Sweroside possesses strong hepatoprotective effect. 2. Sweroside is a promising osteoporosis therapeutic natural product, has anti-osteoporotic effect on the human MG-63 cells and rat osteoblasts.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close